. Author manuscript; available in PMC: 2020 Sep 11.

Published in final edited form as: J Trauma Acute Care Surg. 2020 Sep;89(3):453–457. doi: 10.1097/TA.0000000000002786

Table 1.

Thromboelastography (TEG) parameters measured before, during, and after tPA administration in Case 1.

Timepoint		R-time (min)	CRT-MA (mm)	CFF-MA (mm)	LY30 (%)
	Ref Range	(4.6-9.1)	(52-70)	(15-32)	(0-2.6)
Pre-TPA Bolus #1		6.1	71.9	41.7	0.2
Post-TPA Bolus #1		7.7	70.7	36.0	0.2
Pre-TPA Bolus #2		7.6	72.1	39.1	0.2
Mid-TPA Bolus #2		7.5	67.3	24.3	>22%
Post-TPA Bolus #2		7.1	69.2	29.4	1.6

R-time describes the time to clot formation. MA (maximal amplitude) describes maximum clot strength. CRT-MA (Citrated Rapid TEG-MA) describes the maximum clot strength, but is obtained rapidly by accelerating coagulation. CFF (Citrated Functional Fibrinogen-MA) describes the fibrinogen contribution to clot strength (platelet contribution is excluded). LY30 is the % percent of clot lysis 30 minutes after maximal amplitude.